Previous Article | Next Article 
Journal of Virology, December 2000, p. 11581-11588, Vol. 74, No. 24
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Rous Sarcoma Virus Translation Revisited:
Characterization of an Internal Ribosome Entry Segment in the 5' Leader
of the Genomic RNA
Clarence
Deffaud and
Jean-Luc
Darlix*
LaboRétro, Unité de Virologie
Humaine, Institut National de la Santé et de la Recherche
Médicale, Ecole Normale Supérieure de Lyon, 69364 Lyon
Cedex 07, France
Received 24 May 2000/Accepted 25 September 2000
 |
ABSTRACT |
The 5' leader of Rous sarcoma virus (RSV) genomic RNA and of
retroviruses in general is long and contains stable secondary structures that are critical in the early and late steps of virus replication such as RNA dimerization and packaging and in the process
of reverse transcription. The initiation of RSV Gag translation has
been reported to be 5' cap dependent and controlled by three short open
reading frames located in the 380-nucleotide leader upstream of the Gag
start codon. Translation of RSV Gag would thus differ from that
prevailing in other retroviruses such as murine leukemia virus,
reticuloendotheliosis virus type A, and simian immunodeficiency virus,
in which an internal ribosome entry segment (IRES) in the 5' end of the
genomic RNA directs efficient Gag expression despite stable 5'
secondary structures. This prompted us to investigate whether RSV Gag
translation might be controlled by an IRES-dependent mechanism. The
results show that the 5' leaders of RSV and v-Src RNA exhibit IRES
properties, since these viral elements can promote efficient
translation of monocistronic RNAs in conditions inhibiting 5'
cap-dependent translation. When inserted between two cistrons in a
canonical bicistronic construct, both the RSV and v-Src leaders promote
expression of the 3' cistron. A genetic analysis of the RSV leader
allowed the identification of two nonoverlapping 5' and 3' leader
domains with IRES activity. In addition, the v-Src leader was found to
contain unique 3' sequences promoting an efficient reinitiation of
translation. Taken together, these data lead us to propose a new model
for RSV translation.
 |
INTRODUCTION |
Most eucaryotic mRNAs use the 5'
proximal AUG codon as the site for translation initiation. According to
the scanning model, the 40S ribosomal subunit binds to the methylated
5' cap structure of an mRNA and then scans in the 5'-to-3' direction
until an initiation codon is recognized (39, 42). Genetic
elements within the 5' untranslated region control ribosome access to
the downstream major coding region as follows. (i) The consensus
sequences surrounding the initiator codon
[(A/G)CC AUG G] significantly modulate the efficiency of translation initiation (39). (ii) Stable secondary structures (
G <
50 kcal/mol)
will inhibit translation initiation by halting ribosome scanning
(35, 37). (iii) Small open reading frames (ORFs) upstream of
the major coding region (uORFs) attenuate translation initiation at
downstream AUGs. Two classes of inhibitory uORFs have been described.
In the first class, attenuation occurs because of the intrinsic
inefficiency of the reinitiation mechanism. In the second class,
attenuation is sequence dependent (13, 14, 30, 31, 44,
62-64). These uORFs seem to act in cis on the
translating ribosome, and therefore it has been proposed that the
nascent peptide translated from the uORF specifically interacts with a
component of the translation apparatus to stall the ribosome at the
uORF stop codon (for a review, see reference 41). As
a result, ribosomes cease scanning and do not arrive at AUG codons
downstream of the uORF. However, when the initiation codon of the uORF
is located in a poor initiation context, the majority of the scanning
ribosomes ignores the uORF and initiates translation at a downstream
AUG. This process is known as leaky scanning (34, 38).
In picornaviruses, translation initiation is promoted by a small domain
located within the 5' region of the viral RNA, designated the internal
ribosome entry segment (IRES) (49). In these viruses, the
IRES directs the ribosomes to the translation initiation site in a
cap-independent manner. When inserted between two genes in a canonical
bicistronic construct, the IRES directs expression of the 3' cistron
independently from that of the 5' one. IRESs have also been identified
in retroviruses such as murine leukemia virus (MLV) (Friend MLV and
Moloney MLV) (3, 12, 60), Harvey murine sarcoma virus
(HaMSV) (4), avian reticuloendotheliosis virus REV-A
(40) and simian immunodeficiency virus (SIV)
(47). In these viruses, the 5' leader is formed of stable
secondary structures that are required for several steps of virus
replication such as genomic RNA dimerization and packaging and for the
process of reverse transcription. These stable secondary structures are thought to strongly interfere with ribosome scanning, and
IRES-dependent translation might provide a direct way for the ribosomes
to gain access to the initiation codon of Gag.
As is the case for MLV and SIV, the 5' leader of Rous sarcoma virus
(RSV) is formed of several stable secondary structures necessary for
genomic RNA packaging and reverse transcription (12). In
addition, it contains three conserved uORFs (26). Mutations
of the initiation codon of these greatly perturbs gene expression and
viral replication (17, 45, 46, 54). For example, mutations
of uORF 1 and/or uORF 3 cause a strong reduction of RNA packaging
(17). Although no direct evidence exists for the translation
of these sequences in vivo, their translational properties have been
proposed to be implicated in the regulation of viral replication.
Although conflicting data have been obtained with respect to the impact
of these uORFs on Gag translation, upstream AUG 1 has been found to be
a major ribosome binding site on RSV RNA (10, 11, 52, 53,
54). In vitro, its translation generates the predicted
7-amino-acid peptide (27), thus allowing two models for Gag
translation to be proposed: one based on reinitiation (29)
and the other based on shunt (11).
In view of the discovery of IRESs in MLV, REV-A and SIV, we wanted to
reexamine the mechanism of RSV translation. Data presented here show
that the 5' leader of RSV genomic RNA contains an IRES and therefore
suggest that synthesis of Gag occurs through a cap-independent mechanism. In addition, our results show that the 5' leader of v-Src
RNA contains a unique 3' region, downstream of the region corresponding
to the RSV 5' leader, which favors efficient translation reinitiation.
 |
MATERIALS AND METHODS |
General methods.
Standard procedures were used for
restriction nuclease digestion and plasmid DNA construction. A variant
of Escherichia coli HB101, strain 1035 (recA mutant), was
used for plasmid DNA amplification. The details of the plasmid
constructions are given below. Numbering is with respect to the RNA cap
site (position +1) unless otherwise stated.
DNA constructs.
RSV DNA segments from positions 1 to 379, 1 to 324, 1 to 200, 230 to 379, and 285 to 379 were generated by PCR
using plasmid pLAD4 as the template (5), followed by
digestion with NheI (PCR-added restriction site). The
v-src DNA segments from positions 1 to 473, 1 to 442, and
407 to 473 were generated by PCR using plasmid pSJ2 (5) as
the template, followed by digestion with NheI (PCR-added
restriction site). The MLV DNA fragments from positions 1 to 620 and
212 to 565 were obtained by digestion with NheI of pMLV-CB63
and pMLV-CB39, respectively (3). To construct plasmids
pBi-RSV (1-379), pBi-RSV (1-324), pBi-RSV (1-200), pBi-RSV (230-379), pBi-RSV (285-372), pBi-SRC (1-473), pBi-SRC (1-442), pBi-SRC (407-473), pBi-MLV (1-620), and pBi-MLV (212-651), each fragment described above was inserted between neo and
lacZ of plasmid pBi digested by NheI. To
construct plasmids pBi-RSV loop (1-379), pBi-RSV loop (1-200),
pBi-RSV loop (230-379), pBi-RSV loop (285-379), pBi-SRC loop
(1-473), pBi-SRC loop (1-442), pBi-SRC loop (407-473), and pBi-MLV
loop (1-620), each fragment described above was inserted between
neo and lacZ of plasmid pBi loop digested by
NheI. Plasmids pBi and pBi loop were obtained after
digestion with BstBI and SmaI, Klenow fragment
filling, and subsequent religation of plasmids pMLV-CB63 (3)
and pD 891. The pD 891 plasmid was obtained by inserting into the
HindIII site of plasmid pMLV-CB63 a sequence with the
ability to form a stable stem-loop structure (
G =
50 kcal/mol). To construct pBi-RSV (103-379) and pBi-RSV loop
(103-379), pCB-65 and pCB-65 loop were digested with BstBI and BstEII, Klenow fragment filled, and subsequently
religated. To construct plasmids pM-RSV (1-372) and pM-RSV (1-200)
and plasmid pM-SRC (1-475), each previously described fragment was
inserted into pCB-63 digested with NheI; subsequently the
SmaI-XbaI fragment of each construct, which
contains the RSV or v-src 5' leader and the lacZ
gene, was ligated into pMLV-CB28 digested with EcoRV and
XbaI (3). In plasmids containing the insert RSV
(1-200), the lacZ coding region was fused to the second
codon of uORF 3, which led to a poor initiation context (UGC
AUG ACG); in all other plasmids containing an
RSV insert, the context of the lacZ initiation codon was the
same as that of the wild-type AUGgag
(AGC AUG G). In plasmids containing a
v-Src insert, the context of the lacZ initiation codon was
the same as that of the wild-type AUGv-src
(ACC AUG G). The p
-actin-LacZ
plasmid contains the lacZ gene under the control of the rat
actin promoter. This plasmid was a gift of P. Savatier (Lyon, France).
Plasmids pMLP-P2A and pMLP-PR2A contain the poliovirus protease 2A
coding sequence derived from poliovirus type 1 (Mahoney strain). In
pMLP-P2A, the protease coding sequence was inserted downstream of the
adenovirus major late promoter and its tripartite leader. The pMLP-PR2A
plasmid contains the insert in the reverse orientation and served as a control. These plasmids were gifts of N. Fouillot (Orsay, France).
Cell culture and DNA transfection.
Murine NIH 3T3 cells were
cultured in Dulbecco's modified Eagle's medium (GIBCO-BRL) containing
10% newborn calf serum at 37°C in the presence of 5%
CO2. Avian QT6 cells were grown in Ham's F10 medium (Flow)
supplemented with 10% tryptose phosphate broth (Difco), 5% fetal calf
serum (Eurobio), 1% chicken serum (Eurobio), 0.2% NaHCO3
at 37°C in the presence of 5% CO2. Transfections were
performed on 70% confluent plate by the Fugene method (Roche Inc.)
using 1.5 µg of plasmid DNA. Cotransfection experiments were
performed with the same method using 1.5 µg of monocistonic plasmid
and 1.5 µg of either pMLP-P2A or pMLP-PR2A. Twenty-four hours after
transfection, cells were split in three separate aliquots. After 24 additional hours, cells of the first aliquot were fixed and
histochemically stained for lacZ expression, cells of the second aliquot were lysed for extraction of cellular proteins, and
total RNA was extracted from the third aliquot. Cellular proteins were
submitted to a
-galactosidase enzymatic test, and total RNA was
analyzed by Northern blot or dot blot analysis using a lacZ probe.
lacZ histochemical staining.
After transfection,
cells were fixed with 2% formaldehyde and 0.2% glutaraldehyde, washed
twice with phosphate-buffered saline and incubated for 6 h at
37°C in phosphate-buffered saline containing 5-bromo-4-chloro-3-indolyl-
-D-glucoronic acid (X-Gal) (1 mg/ml), ferrocyanure (4 mM), ferrycyanure (4 mM), and MgCl2
(4 mM).
RNA extraction and slot blot and Northern blot analysis.
Extraction of cellular RNAs from transfected cells was performed using
the Trizol reagent (Life Technologies) according to the manufacturer's
instructions. Northern blot and slot blot analysis were performed as
previously described (33). A 32P-labeled probe
complementary to the lacZ gene
(ClaI-ClaI fragment of pCB 63) was generated
using the prim-It room temperature kit (Stratagene).
Protein extraction and enzymatic activities.
Cellular
proteins were extracted using the
-galactosidase enzyme assay kit
(Promega). Protein concentration was determined using the Micro
bicinchoninic acid kit (Pierce). Neomycin phosphotransferase (encoded
by neo) activity was measured by [
-32P]ATP
phosphate transfer to neomycin (57).
-Galactosidase
activity was determined spectrophotometrically (
-galactosidase
enzyme assay system; Promega). In order to check for linearity of the assays and to determine the relative activities of neomycin and
-galactosidase in each cell extract, an internal standard curve was
generated by serial dilutions of the cell extract giving the strongest
Neo or
-galactosidase activity.
 |
RESULTS |
Translation mediated by 5' leader of RSV genomic and
v-src RNAs is not inhibited by poliovirus protease 2A.
In poliovirus-infected cells, cap-dependent translation is strongly
inhibited by the viral protease 2A (15, 19, 28). Poliovirus
protease 2A cleaves the initiation factor eIF4G, a subunit of eIF4F,
which bridges together the ribosome and the 5' cap structure of an
mRNA. Intact eIF4G is required in cap-dependent translation mediated by
canonical scanning, leaky scanning, reinitiation, and shunt mechanisms.
As has been described previously, transient expression of poliovirus
protease 2A strongly inhibits cap-dependent translation but not
IRES-dependent translation (3, 4, 21). To examine whether
gag and v-src translation is cap-dependent, a
monocistronic construct with the RSV or v-src 5' leader
sequences upstream of a reporter gene (lacZ) (Fig.
1 and 2)
was transfected into NIH 3T3 cells with a plasmid encoding poliovirus
protease 2A (pMLP-P2A). In this plasmid, the coding region of the
protease 2A is preceded by the adenovirus major late promoter and its
tripartite leader, which has been shown to promote efficient
translation even in the presence of the poliovirus protease 2A
(16). A plasmid containing the protease 2A coding sequence
in the reverse orientation was used as a negative control (pMLP-PR2A).
The p
-actin-LacZ plasmid was used as a positive control for
cap-dependent translation, and pMLV-CB93 with the MLV IRES was used as
a positive control for IRES-dependent translation. Two days after DNA
transfection, cells were submitted to histochemical staining for
-galactosidase activity (see Fig. 3). In addition, translation
efficiency was estimated from the ratio between the
-galactosidase
activity and the concentration of lacZ mRNA (expressed in
arbitrary units) (see Fig. 4 for a summary of the results).

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 1.
Genetic organization and expression of RSV. (A) RSV
provirus. LTR, long terminal repeat; SD, splice donor site; SA, splice
acceptor site. Numbering is with respect to the RNA cap site (position
+1). (B) Viral RNAs (genomic RNA and spliced RNAs).
|
|

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 2.
Schematic representation of the 5' leader of RSV genomic
and v-src RNAs. The uORFs are represented by rectangles.
PBS, primer binding site; SD, splice donor site. Numbering is with
respect to the cap site (position +1). The contexts for the initiation
codons were as follows: for uORF 1, UUG AUG
A; for uORF 2, UGC AUG A;
for uORF 3, UCG AUG A; for Gag,
AGC AUG G; and for v-src,
ACC AUG G. For details of the
molecular constructs, see Materials and Methods.
|
|
Histochemical staining of NIH 3T3 cells for
lacZ (Fig.
3) revealed that poliovirus protease 2A
drastically inhibited cap-dependent
translation since no blue cells
were detected when p

-actin
lacZ and pMLP-P2A were
coexpressed by DNA transfection (Fig.
3, compare
panels A and C). In
contrast, efficient

-galactosidase expression
occurred after
cotransfection of either pMLP-P2A or pMLP-PR2A
with pMLV-CB93, pM-RSV
(1-379), pM-RSV (1-200), or pM-SRC (1-479)
(data shown for pM-RSV
(1-379) [Fig.
3, compare panels B and D]).
It should also be noted
that the expression of poliovirus protease
2A in NIH 3T3 cells caused a
round-shaped morphology previously
reported to be a proapoptotic
phenotype (
2,
23) (Fig.
3B).
In contrast, cells
cotransfected with pMLP-PR2A and any one of
the monocistronic
lacZ-carrying plasmids exhibited a normal morphology
(Fig.
3C and D).

View larger version (109K):
[in this window]
[in a new window]
|
FIG. 3.
Histochemical staining of NIH 3T3 cells for
lacZ expression. (A) Cotransfection of pMLP-P2A and
p -actin-LacZ. The expression of poliovirus protease 2A inhibits
lacZ expression. (B) Cotransfection of pMLP-P2A and pM-RSV
(1-379). The expression of poliovirus protease 2A does not inhibit
lacZ expression, and cells with a round morphology can be
visualized. (C) Cotransfection of pMLP-PR2A and p -actin-LacZ. (D)
Cotransfection of pMLP-PR2A and pM-RSV (1-379).
|
|
The levels of

-galactosidase activity and of recombinant
lacZ RNA in cells cotransfected with the
lacZ
construct and pMLP-P2A
or pMLP-PR2A were monitored, and the values
reported are relative
levels of enzymatic activity (Fig.
4). In NIH 3T3 cells expressing
the
p

-actin
lacZ construct and poliovirus protease 2A, the
relative
level of

-galactosidase activity was drastically lower than
that
in control cells, confirming that protease 2A strongly inhibited
cap-dependent translation (Fig.
4). In contrast, coexpression
of
protease 2A and pMLV-CB93, pM-RSV (1-379), pM-RSV (1-200),
or pM-SRC
(1-479) resulted in relative levels of

-galactosidase
activity
similar to those obtained in the absence of poliovirus
protease 2A
(Fig.
4). These findings indicate that synthesis of
RSV Gag and v-Src
does not proceed via a cap-dependent mechanism
but most probably uses
an IRES. In addition, these results indicate
that the AUG of uORF 3 is
a strong site for translation initiation
and that ribosome recognition
at this site is probably cap independent
[Fig.
2, pM-RSV (1-200)].

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 4.
Effect of poliovirus protease 2A on translation
efficiency of recombinant RSV lacZ RNA. (A) The recombinant
plasmids contain the MLV leader (positions 28 to 620) for pMLV-CB 93;
the RSV leaders (positions 1 to 379) and (positions 1 to 200) for
pM-RSV (1-379) and pM-RSV (1-200), respectively; and the
v-src leader (positions 1 to 473) for pM-SRC (1-473). (B)
pMLP-P2A encodes the poliovirus protease 2A under the control of the
adenovirus late promoter; pMLP-PR2A has the coding sequence of
poliovirus protease 2A in the reverse orientation and was used as a
control. Cotransfections were performed for each recombinant plasmid
with pMLP-P2A or pMLP-PR2A. Forty-eight hours later, lacZ
expression was calculated as the ratio between
-galactosidase-specific activity and the amount of recombinant
lacZ RNA present in transfected cells (see Materials and
Methods). Results are in arbitrary units and are the averages of
results from two independent experiments.
|
|
5' leaders of RSV and v-src RNAs promote efficient
translation of downstream cistron in a bicistronic RNA.
In order
to further characterize the translation properties of the 5' leaders of
RSV and v-src RNAs, bicistronic plasmids were constructed in
which the 5' leader of RSV genomic or v-src RNAs was
inserted between the neo and lacZ genes. In these
constructs, a cytomegalovirus promoter allows the production of
bicistronic RNAs in cell culture (Fig.
5). Expression of the 5' cistron
(neo) is cap dependent, whereas that of the 3' cistron
(lacZ) can occur only if the intercistronic region contains
a functional IRES (3, 4, 12, 40, 49). These bicistronic
plasmids were expressed in avian QT6 cells by means of DNA
transfection. For each experiment, the relative efficiencies of
neo and lacZ translation were calculated as the
ratio of the specific enzymatic activity (Neo or
-galactosidase) to
the level of cellular bicistronic mRNA (see Materials and Methods).

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 5.
Schematic representation of the bicistronic constructs
used for transfection of QT6 cells. Po CMV, cytomegalovirus early
promoter; SV40, simian virus 40. (A and B) DNA constructs direct
synthesis of bicistronic capped RNAs. However, the presence of a stable
stem-loop structure just upstream of neo in the construct
shown in panel B is thought to inhibits neo expression
(36). (C) Sequence and computer-predicted structure of the
stem-loop structure ( G = 50 kcal/mol).
|
|
To rule out that a cryptic promoter and/or cryptic splice sites could
function during the expression of the bicistronic constructs,
RNAs from
transfected cells were analyzed by Northern analysis
using a
lacZ probe. As shown in Fig.
6, lanes 1, 3, 4, 6, 8, and
10, only one
major RNA species of the expected size was detected.
Thus, it can be
concluded that all
lacZ RNAs synthesized in transfected
QT6
cells were bicistronic.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 6.
Northern blot analysis of recombinant bicistronic
neo-lacZ mRNAs produced in QT6 cells. Total RNA was
extracted from QT6 cells 48 h after transfection with the
bicistronic construct pBi-RSV (1-379) (lane 1), pBi-RSV loop (1-379)
(lane 2), pBi-RSV (103-379) (lane 3), pBi-RSV (230-379) (lane 4),
pBi-RSV loop (230-379) (lane 5), pBi-RSV (1-200) (lane 6), pBi-RSV
loop (1-200) (lane 7), pBi-SRC (1-473) (lane 8), pBi-SRC loop
(1-473) (lane 9), pBi-SRC (407-473) (lane 10), or pBi-SRC loop
(407-473) (lane 11) or a negative control (lane 12). RNAs were
subjected to electrophoresis in an 0.8% agarose gel and transferred to
a nitrocellulose membrane. Hybridization was performed with a
32P-labeled probe corresponding to nucleotides 829 to 3105 of the lacZ cistron (ClaI-ClaI
fragment). The 28S and 18S rRNAs were revealed by ethidium bromide
staining prior to RNA transfer. Positions of the 18S and 28S rRNA and
of the bicistronic neo-lacZ mRNAs are indicated.
|
|
As shown in Fig.
7, the MLV IRES directed
a high level of
lacZ expression (Fig.
7, lane 2) whereas the
MLV IRES in the reverse
orientation was inactive (Fig.
7, lane 3). The
5' leader of RSV
and v-
src RNAs were active in the canonical
bicistronic assay
(Fig.
7, lanes 4 and 10). In an attempt to map the
regions of
the RSV and v-
src 5' leaders responsible for the
IRES activity,
bicistronic DNAs were constructed and transfected into
QT6 cells
(Fig.
7, lanes 4 to 9 for RSV RNA and lanes 11 and 12 for
v-Src
RNA). Clearly two domains of the RSV leader exhibited IRES
activity,
namely nucleotides (nt) 1 to 200 and nt 285 to 379, corresponding
to the 5' and 3' ends of the leader (Fig.
7, lanes 7 and
9). Addition
of nt 230 to 284 increased by about twofold the IRES
activity
of the 3' region of the leader using the canonical bicistronic
assays (Fig.
7, lanes 6 and 7). The 5' domain (nt 1 to 200) had
significantly a lower activity than the 3' domain (nt 285 to 379)
(Fig.
7, compare lanes 7 and 9). Finally, a unique domain of the
v-
src leader (position 407 to 473 [Fig.
2]) was found to
direct
strong
lacZ expression (Fig.
7, lane 11). To rule out
the possibility
that
lacZ expression could be due to
translation reinitiation,
we examined the influence of a stable 5'
stem-loop structure on
the relative expression of
neo and
lacZ genes.

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 7.
Synthesis of -galactosidase directed by bicistronic
neo-LacZ RNAs in QT6 cells. Transfection of the bicistronic plasmids
was performed by the Fugene method (Materials and Methods). Two days
later, -galactosidase-specific activity was measured on cellular
extracts and neo-lacZ RNA was quantified by slot blot
analysis. Efficiency of lacZ translation for each
bicistronic RNA is given as the ratio of -galactosidase-specific
activity per arbitrary unit of bicistronic neo-lacZ mRNA.
Results are the averages of the results from two independent
experiments.
|
|
Influence of 5' stem-loop structure on the translation of
bicistronic neo-lacZ mRNAs.
A stable stem-loop
structure (
G =
50 kcal/mol) was inserted 30 nucleotides upstream of the neo AUG codon in the bicistronic plasmids
(Fig. 5C). This stem-loop structure was designed to block ribosome
scanning and thus to impair cap-dependent translation of neo
cistron and, as a consequence, of lacZ in situations where reinitiation is driving translation of the second cistron of this bicistronic RNA (37). Northern blot analysis confirmed that the mRNAs synthesized in the transfected QT6 cells were bicistronic (Fig. 6, lanes 2, 5, 7, 9, and 11).
As shown in Fig.
8, the presence of the
stable stem-loop structure reduced
neo expression by 50 to
80% with respect to the
control. In contrast,
lacZ
expression directed by pBi-MLV loop
(1-620), pBi-RSV loop (1-379),
pBi-RSV loop (230-379), pBi-RSV
loop (285-379), and pBi-SRC loop
(1-473) was not inhibited. Interestingly,
the expression of
lacZ was even enhanced with pBi-RSV loop (103-379)
(Fig.
8,
lane 3) and pBi-RSV loop (1-200) (Fig.
8, lane 6). This
confirms that
in the corresponding RNAs, translation of the
lacZ cistron
is independent from that of the
neo cistron and that the
intercistronic region contains a functional IRES. However, in
pBi-SRC
loop (403-476) bicistronic RNA, the presence of the stem-loop
decreased
lacZ translation efficiency by 70% with respect
to the
control (Fig.
8, lane 9). This shows that in these bicistronic
RNAs, the translations of
neo and
lacZ do not
occur independently,
indicating that the 5' leader of v-Src RNA from
positions 403
to 476 does not contain an IRES but instead allows
efficient reinitiation.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 8.
Influence of stable 5' stem-loop structure on
neo and lacZ expression. QT6 cells were
transfected with a bicistronic plasmid allowing synthesis of a
bicistronic RNA with or without the potential to form a very stable
secondary structure ( G = 50 kcal/mol) 5' to the
neo cistron. The inserts used as the intercistronic spacers
are indicated at the top of the figure. Forty-eight hours later, the
percent variation of Neo and -galactosidase enzymatic activities in
the presence or absence of the 5' stem-loop structure was calculated
(activity with the stem-loop activity without the stem
loop)/activity without the stem-loop × 100).
|
|
 |
DISCUSSION |
The 5' leader of avian sarcoma and leukosis virus (ASLV) and of
other related oncoviruses is long and contains several stable secondary
structures that are involved in key functions of the viral life cycle
such as dimerization and packaging of the genomic RNA and in the
process of reverse transcription (8, 11, 65). The 5' leaders
of several MLV oncoviruses and SIV each contain an IRES (4, 5, 40,
47, 60). This suggests that to initiate translation of the viral
RNA, ribosomes do not scan the 5' leader but are directly recruited at
or near the Gag initiation codon. This is in agreement with the
observation that stable secondary structures do not allow efficient
ribosome scanning (35, 37). In addition to stable secondary
structures, the 5' leader of RSV RNA contains three conserved, short
ORFs (uORFs) which seem to constitute an additional barrier for
efficient translation initiation mediated by any of the known
cap-dependent mechanisms (scanning, leaky scanning,
and reinitiation). This prompted us to reexamine the mechanism
of translation initiation of RSV RNA.
As first indicated by the results obtained with monocistronic RNAs, the
5' leaders of RSV and v-src RNAs most probably both contain
an IRES that drives translation, since expression of the poliovirus
protease 2A, which cleaves the initiation factor eIF4G, thus impairing
cap-dependent translation, had no effect on
-galactosidase synthesis
(Fig. 3 and 4). In the monocistronic RSV lacZ RNA, which contains the 5' leader from position 1 to 200, lacZ
translation uses the initiation codon of uORF 3, which is in a poor
consensus context (UGC AUG ACC).
Therefore, if lacZ expression were to occur by a canonical
ribosome scanning, the AUG of uORF 3 would have probably been poorly
recognized by the ribosomes and thus lacZ would have been
poorly expressed. On the contrary, pM-RSV (1-200) was well expressed
in the presence or absence of protease 2A (Fig. 4) and thus most
probably was expressed by an IRES-directed mechanism. These findings
were confirmed by investigating the translation of canonical
bicistronic neo-lacZ RNAs in which neo expression
is 5' cap dependent whereas that of lacZ must rely on either
reinitiation or the presence of an IRES (Fig. 5). As shown in Fig. 7
and 8, both the RSV and v-src leaders are able to drive
translation of the 3' cistron of bicistronic RNA independently from
that of the 5' cistron, a property of IRESs (49).
Interestingly, the first 200 nt 5' of the RSV leader display a low
level of IRES activity in avian cells (Fig. 7, lane 9) whereas the last
150 nt (positions 230 to 379) 3' of the leader direct a strong
IRES-dependent translation (Fig. 7, lane 6). Also, site-directed mutagenesis suggests that the AUG of Gag is probably an integral part
of the RSV IRES. The AUG of Gag was changed to a
CUG known to be functional for the synthesis of MLV
GlycoGag (55, 60) and although the CUG was in an optimal
context (AGC CUG G in place of AGC AUG G)
(38), this mutation completely inhibited the RSV IRES
activity (data not shown). This bipartite IRES in the RSV 5' leader may
ensure a high level of RSV and more generally of ASLV expression in
infected cells. Possible interactions between the 5' and 3' domains of
this bipartite IRES, as suggested by the scheme shown in Fig.
9, are presently under investigation.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 9.
Schematic representation of RSV 5' leader structure upon
ribosome binding to uORF 1. Numbering is with respect to the cap site
(position +1). PBS, primer binding site. In this model, nucleotides
from positions 1 to 77 are engaged in ribosome binding at uORF 1 (10, 11). Structures described in other models
(26) and conserved in this model are indicated; the L3
stem-loop is implicated in RSV RNA dimerization (5, 20), and
the US-IR stem-loop is implicated in the initiation of reverse
transcription (43). The G of the structure is
estimated to be 148 kcal/mol. Note that the extended secondary
structure with stem-loops and bulges (from the PBS to the AUG of Gag)
corresponds to the bipartite IRES.
|
|
As does the RSV 5' leader (positions 1 to 379), the v-src
leader contains a unique sequence (positions 407 to 473) (Fig. 2) with
a stop codon in-frame with the gag start codon. This small v-src sequence was found to promote a high level of
translation reinitiation (Fig. 7, lane 12, and Fig. 8, lane 9). These
findings would thus favor the notion that translation of
v-src is mediated by the IRES of the RSV 5' leader followed
by a reinitiation mechanism between the AUGgag
and AUGv-src. In agreement with this, a previous
work has shown that mutating the stop codon downstream of the
AUGgag resulted in the production of a v-Src
fusion protein (32).
In the light of the present data, previous studies on the RSV should be
reinterpreted. We present an RSV translation model (Fig. 9) that could
explain how mutating the initiation codon of uORF 1 or uORF 3 can
strongly affect RSV RNA translation and packaging (17, 45,
46). Our model implies that the ribosome is binding to and
stalling at uORF 1 (10, 11) due to stable secondary
structures located downstream of uORF 1 which are required for internal
translation initiation of Gag and RNA packaging. In fact, a
computer-predicted structure of the RSV 5' leader where a ribosome is
bound to uORF 1 highlights an extended stable structure with a
G of
148 kcal/mol (Fig. 9). In this model the RSV IRES maps to a Y-like structure, since the long stem and the two short upper
stem-loops each appear to contribute to the IRES activity (Fig. 7,
lanes 5 to 8, and Fig. 9). Also, this model structure suggests that
translation reinitiation at uORF 3 or gag is very unlikely
due to the predicted stable RNA structures (Fig. 9) (12, 25,
37). In addition, ribosome stalling at the level of uORF 1 (10) might require an interaction between the uORF-encoded peptide and the translation apparatus which has been shown to block
ribosome dissociation at the stop codon (6, 7, 41, 61). In
agreement with this notion, the RSV uORF 1 encoded peptide (MAGPLIP)
displays similarities with the inhibitory peptide encoded by the uORF
present in the mammalian S-adenosylmethionine decarboxylase RNA (MAGDIS) (31). Mutating the AUG codon of uORF 1 might
allow the preinitiation complexes to scan downstream of uORF 1 and thus unwind some RNA structures engaged in IRES activity and RNA packaging. Consistent with this hypothesis, after translation termination, the 40S
subunits can resume scanning but progression is easily inhibited by
secondary structures (25); in contrast, preinitiation complexes can unfold more-stable secondary structures
(
G =
30kcal/mol) (35, 37).
The existence of an IRES in the 5' leader of RSV RNA and other
retroviruses such as MLV (3, 61), REV-A (40) and
SIV (47) should direct ribosome recruitment at or near the
Gag translation start site, thus bypassing the secondary structures
which are required for the process of reverse transcription.
Furthermore, colocalization of the RSV IRES with the dimerization and
packaging sequences favors the notion that the full-length retroviral
RNA could be used both as a messenger RNA and as pregenomic RNA
(5, 11), as in the case of poliovirus RNA (22).
It has recently been shown that uORF 3 is located in stem-loop O3,
which is capable of promoting encapsidation of an heterologous RNA
(1). In addition, a previous report shows that uORF 3 is
critical for RNA encapsidation, probably through its translational
properties (18). The present findings suggest that uORF 3 is
not translated after reinitiation from uORF 1 but uses an
IRES-dependent mechanism. This, however, has major consequences because
IRES-dependent translation does follow the same rules as classical
cap-dependent translation. In that respect, trans-acting
factors are thought to play a major role in internal initiation. In
particular, it has been shown that Gag acts as a translational
repressor of RSV RNA which would be capable of sorting viral RNA for
translation or encapsidation (5, 59). It is therefore
tempting to speculate that, by binding to the RSV IRES, Gag can
regulate its own translation and, therefore, virus assembly.
Interestingly IRES-dependent translation might well provide some
advantages to the virus since it occurs independently of the initiation
factor eIF4E which recognizes the 5' cap structure and regulates
cellular protein synthesis (48, 50, 51). In that respect,
the retroviral IRES-directed translation, which avoids eIF4E
regulation, may represent a strategy to favor viral protein synthesis,
especially during the G2/M phase of the cell cycle, when cap-dependent
translation is significantly decreased (9, 56, 58).
 |
ACKNOWLEDGMENTS |
We thank Christelle Daudé for technical assistance,
Nathalie Fouillot for the gift of plasmids pMLP-P2A and pMLP-PR2A,
Pierre Savatier for the gift of plasmid p
-Actin-LacZ, and Edmund
Derrington for a critical reading of the manuscript.
This work was supported by grants from ANRS and MGEN. Clarence Deffaud
is supported by an ARC fellowship.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: LaboRétro,
Unité de Virologie Humaine #412, Institut National de la
Santé et de la Recherche Médicale, Ecole Normale
Supérieure de Lyon, 46 Allée d' Italie, 69364 Lyon Cedex
07, France. Phone: 33-472-72-81-69. Fax: 33-472-72-86-86. E-mail:
Jean-Luc.Darlix{at}ens-lyon.fr.
 |
REFERENCES |
| 1.
|
Banks, J. D., and M. L. Linial.
2000.
Secondary structure analysis of a minimal avian leukosis-sarcoma virus packaging signal.
J. Virol.
74:456-464[Abstract/Free Full Text].
|
| 2.
|
Barco, A.,
E. Feduchi, and L. Carrasco.
2000.
A stable HeLa cell line that inducibly expresses poliovirus 2Apro: effects on cellular and viral gene expression.
J. Virol.
74:2383-2392[Abstract/Free Full Text].
|
| 3.
|
Berlioz, C., and J.-L. Darlix.
1995.
An internal ribosomal entry mechanism promotes translation of murine leukemia virus gag polyprotein precursors.
J. Virol.
69:2214-2222[Abstract].
|
| 4.
|
Berlioz, C.,
C. Torrent, and J.-L. Darlix.
1995.
An internal ribosomal entry signal in the rat VL30 region of the Harvey murine sarcoma virus leader and its use in dicistronic retroviral vectors.
J. Virol.
69:6400-6407[Abstract].
|
| 5.
|
Bieth, E.,
C. Gabus, and J.-L. Darlix.
1990.
A study of the dimer formation of Rous sarcoma virus RNA and of its effect on viral protein synthesis in vitro.
Nucleic Acids Res.
18:119-127[Abstract/Free Full Text].
|
| 6.
|
Cao, J., and A. P. Geballe.
1996.
Coding sequence-dependent ribosomal arrest at termination of translation.
Mol. Cell. Biol.
16:603-608[Abstract].
|
| 7.
|
Cao, J., and A. P. Geballe.
1996.
Inhibition of nascent-peptide release at translation termination.
Mol. Cell. Biol.
16:7109-7114[Abstract].
|
| 8.
|
Corbin, A., and J.-L. Darlix.
1996.
Functions of the 5' leader of murine leukemia virus genomic RNA in virion structure, viral replication and pathogenesis, and MLV-derived vectors.
Biochimie
78:632-638[Medline].
|
| 9.
|
Cornelis, S.,
G. Bruynooghe,
S. Van Huffel,
S. Tinton, and R. Beyaert.
2000.
Identification and characterization of a novel cell cycle-regulated internal ribosome entry site.
Mol. Cell
5:597-605[CrossRef][Medline].
|
| 10.
|
Darlix, J.-L.,
P. F. Spahr,
P. A. Bromley, and J. C. Jaton.
1979.
In vitro, the major ribosome binding site on Rous sarcoma virus RNA does not contain the nucleotide sequence coding for the N-terminal amino acids of the gag gene product.
J. Virol.
29:597-611[Abstract/Free Full Text].
|
| 11.
|
Darlix, J. L.,
M. Zuker, and P. F. Spahr.
1982.
Structure-function relationship of Rous sarcoma virus leader RNA.
Nucleic Acids Res.
10:5183-5196[Abstract/Free Full Text].
|
| 12.
|
Deffaud, C., and J.-L. Darlix.
2000.
Characterization of an internal ribosomal entry segment in the 5' leader of murine leukemia virus env RNA.
J. Virol.
74:846-850[Abstract/Free Full Text].
|
| 13.
|
Degnin, C. R.,
M. R. Schleiss,
J. Cao, and A. P. Geballe.
1993.
Translational inhibition mediated by a short upstream open reading frame in the human cytomegalovirus gpUL4 (gp48) transcript.
J. Virol.
67:5514-5521[Abstract/Free Full Text].
|
| 14.
|
Delbecq, P.,
M. Werner,
A. Feller,
R. K. Filipkowski,
F. Messenguy, and A. Pierard.
1994.
A segment of mRNA encoding the leader peptide of the CPA1 gene confers repression by arginine on a heterologous yeast gene transcript.
Mol. Cell. Biol.
14:2378-2390[Abstract/Free Full Text].
|
| 15.
|
Devaney, M. A.,
V. N. Vakharia,
R. E. Lloyd,
E. Ehrenfeld, and M. J. Grubman.
1988.
Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex.
J. Virol.
62:4407-4409[Abstract/Free Full Text].
|
| 16.
|
Dolph, P. J.,
J. T. Huang, and R. J. Schneider.
1990.
Translation by the adenovirus tripartite leader: elements which determine independence from cap-binding protein complex.
J. Virol.
64:2669-2677[Abstract/Free Full Text].
|
| 17.
|
Donze, O.,
P. Damay, and P. F. Spahr.
1995.
The first and third uORFs in RSV leader RNA are efficiently translated: implications for translational regulation and viral RNA packaging.
Nucleic Acids Res.
23:861-868[Abstract/Free Full Text].
|
| 18.
|
Donze, O., and P. F. Spahr.
1992.
Role of the open reading frames of Rous sarcoma virus leader RNA in translation and genome packaging.
EMBO J.
11:3747-3757[Medline].
|
| 19.
|
Etchison, D.,
S. C. Milburn,
I. Edery,
N. Sonenberg, and J. W. Hershey.
1982.
Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex.
J. Biol. Chem.
257:14806-14810[Abstract/Free Full Text].
|
| 20.
|
Fosse, P.,
N. Motte,
A. Roumier,
C. Gabus,
D. Muriaux,
J.-L. Darlix, and J. Paoletti.
1996.
A short autocomplementary sequence plays an essential role in avian sarcoma-leukosis virus RNA dimerization.
Biochemistry
35:16601-16609[CrossRef][Medline].
|
| 21.
|
Fouillot, N.,
S. Tlouzeau,
J. M. Rossignol, and O. Jean-Jean.
1993.
Translation of the hepatitis B virus P gene by ribosomal scanning as an alternative to internal initiation.
J. Virol.
67:4886-4895[Abstract/Free Full Text].
|
| 22.
|
Gamarnik, A. V., and R. Andino.
1998.
Switch from translation to RNA replication in a positive-stranded RNA virus.
Genes Dev.
12:2293-2304[Abstract/Free Full Text].
|
| 23.
|
Goldstaub, D.,
A. Gradi,
Z. Bercovitch,
Z. Grosmann,
Y. Nophar,
S. Luria,
N. Sonenberg, and C. Kahana.
2000.
Poliovirus 2A protease induces apoptotic cell death.
Mol. Cell. Biol.
20:1271-1277[Abstract/Free Full Text].
|
| 24.
|
Grant, C. M., and A. G. Hinnebusch.
1994.
Effect of sequence context at stop codons on efficiency of reinitiation in GCN4 translational control.
Mol. Cell. Biol.
14:606-618[Abstract/Free Full Text].
|
| 25.
|
Grant, C. M., and A. G. Hinnebusch.
1994.
Effect of sequence context at stop codons on efficiency of reinitiation in GCN4 translational control.
Mol. Cell. Biol.
14:606-618.
|
| 26.
|
Hackett, P. B.,
M. W. Dalton,
D. P. Johnson, and R. B. Petersen.
1991.
Phylogenetic and physical analysis of the 5' leader RNA sequences of avian retroviruses.
Nucleic Acids Res.
19:6929-6934[Abstract/Free Full Text].
|
| 27.
|
Hackett, P. B.,
R. B. Petersen,
C. H. Hensel,
F. Albericio,
S. I. Gunderson,
A. C. Palmenberg, and G. Barany.
1986.
Synthesis in vitro of a seven amino acid peptide encoded in the leader RNA of Rous sarcoma virus.
J. Mol. Biol.
190:45-57[CrossRef][Medline].
|
| 28.
|
Hellen, C. U.,
M. Facke,
H. G. Krausslich,
C. K. Lee, and E. Wimmer.
1991.
Characterization of poliovirus 2A proteinase by mutational analysis: residues required for autocatalytic activity are essential for induction of cleavage of eukaryotic initiation factor 4F polypeptide p220.
J. Virol.
65:4226-4231[Abstract/Free Full Text].
|
| 29.
|
Hensel, C. H.,
R. B. Petersen, and P. B. Hackett.
1989.
Effects of alterations in the leader sequence of Rous sarcoma virus RNA on initiation of translation.
J. Virol.
63:4986-4990[Abstract/Free Full Text].
|
| 30.
|
Hill, J. R., and D. R. Morris.
1992.
Cell-specific translation of S-adenosylmethionine decarboxylase mRNA. Regulation by the 5' transcript leader.
J. Biol. Chem.
267:21886-21893[Abstract/Free Full Text].
|
| 31.
|
Hill, J. R., and D. R. Morris.
1993.
Cell-specific translational regulation of S-adenosylmethionine decarboxylase mRNA. Dependence on translation and coding capacity of the cis-acting upstream open reading frame.
J. Biol. Chem.
268:726-731[Abstract/Free Full Text].
|
| 32.
|
Hughes, S.,
K. Mellstrom,
E. Kosik,
F. Tamanoi, and J. Brugge.
1984.
Mutation of a termination codon affects src initiation.
Mol. Cell. Biol.
4:1738-1746[Abstract/Free Full Text].
|
| 33.
|
Khandjian, E. W., and C. Meric.
1986.
A procedure for Northern blot analysis of native RNA.
Anal. Biochem.
159:227-232[CrossRef][Medline].
|
| 34.
|
Kozak, M.
1995.
Adherence to the first-AUG rule when a second AUG codon follows closely upon the first.
Proc. Natl. Acad. Sci. USA
92:2662-2666[Abstract/Free Full Text]. (Erratum, 92:7134.)
|
| 35.
|
Kozak, M.
1989.
Circumstances and mechanisms of inhibition of translation by secondary structure in eucaryotic mRNAs.
Mol. Cell. Biol.
9:5134-5142[Abstract/Free Full Text].
|
| 36.
|
Kozak, M.
1987.
Effects of intercistronic length on the efficiency of reinitiation by eucaryotic ribosomes.
Mol. Cell. Biol.
7:3438-3445[Abstract/Free Full Text].
|
| 37.
|
Kozak, M.
1986.
Influences of mRNA secondary structure on initiation by eukaryotic ribosomes.
Proc. Natl. Acad. Sci. USA
83:2850-2854[Abstract/Free Full Text].
|
| 38.
|
Kozak, M.
1999.
Initiation of translation in prokaryotes and eukaryotes.
Gene.
234:187-208[CrossRef][Medline].
|
| 39.
|
Kozak, M.
1989.
The scanning model for translation: an update.
J. Cell. Biol.
108:229-241[Abstract/Free Full Text].
|
| 40.
|
Lopez-Lastra, M.,
C. Gabus, and J.-L. Darlix.
1997.
Characterization of an internal ribosomal entry segment within the 5' leader of avian reticuloendotheliosis virus type A RNA and development of novel MLV-REV-based retroviral vectors.
Hum. Gene Ther.
8:1855-1865[Medline].
|
| 41.
|
Lovett, P. S., and E. J. Rogers.
1996.
Ribosome regulation by the nascent peptide.
Microbiol. Rev.
60:366-385[Abstract/Free Full Text].
|
| 42.
|
Merrick, W. C.
1992.
Mechanism and regulation of eukaryotic protein synthesis.
Microbiol. Rev.
56:291-315[Abstract/Free Full Text].
|
| 43.
|
Miller, J. T.,
Z. Ge,
S. Morris,
K. Das, and J. Leis.
1997.
Multiple biological roles associated with the Rous sarcoma virus 5' untranslated RNA U5-IR stem and loop.
J. Virol.
71:7648-7656[Abstract].
|
| 44.
|
Mize, G. J.,
H. Ruan,
J. J. Low, and D. R. Morris.
1998.
The inhibitory upstream open reading frame from mammalian S-adenosylmethionine decarboxylase mRNA has a strict sequence specificity in critical positions.
J. Biol. Chem.
273:32500-32505[Abstract/Free Full Text].
|
| 45.
|
Moustakas, A.,
T. S. Sonstegard, and P. B. Hackett.
1993.
Alterations of the three short open reading frames in the Rous sarcoma virus leader RNA modulate viral replication and gene expression.
J. Virol.
67:4337-4349[Abstract/Free Full Text].
|
| 46.
|
Moustakas, A.,
T. S. Sonstegard, and P. B. Hackett.
1993.
Effects of the open reading frames in the Rous sarcoma virus leader RNA on translation.
J. Virol.
67:4350-4357[Abstract/Free Full Text].
|
| 47.
|
Ohlmann, T.,
M. Lopez-Lastra, and J.-L. Darlix.
2000.
An internal ribosome entry segment promotes translation of the simian immunodeficiency virus genomic RNA.
J. Biol. Chem.
275:11899-11906[Abstract/Free Full Text].
|
| 48.
|
Pain, V. M.
1996.
Initiation of protein synthesis in eukaryotic cells.
Eur. J. Biochem.
236:747-771[Medline].
|
| 49.
|
Pelletier, J., and N. Sonenberg.
1988.
Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA.
Nature
334:320-325[CrossRef][Medline].
|
| 50.
|
Pestova, T. V.,
C. U. Hellen, and I. N. Shatsky.
1996.
Canonical eukaryotic initiation factors determine initiation of translation by internal ribosomal entry.
Mol. Cell. Biol.
16:6859-6869[Abstract].
|
| 51.
|
Pestova, T. V.,
I. N. Shatsky, and C. U. Hellen.
1996.
Functional dissection of eukaryotic initiation factor 4F: the 4A subunit and the central domain of the 4G subunit are sufficient to mediate internal entry of 43S preinitiation complexes.
Mol. Cell. Biol.
16:6870-6878[Abstract].
|
| 52.
|
Petersen, R. B., and P. B. Hackett.
1985.
Characterization of ribosome binding on Rous sarcoma virus RNA in vitro.
J. Virol.
56:683-690[Abstract/Free Full Text].
|
| 53.
|
Petersen, R. B.,
C. H. Hensel, and P. B. Hackett.
1984.
Identification of a ribosome-binding site for a leader peptide encoded by Rous sarcoma virus RNA.
J. Virol.
51:722-729[Abstract/Free Full Text].
|
| 54.
|
Petersen, R. B.,
A. Moustakas, and P. B. Hackett.
1989.
A mutation in the short 5'-proximal open reading frame on Rous sarcoma virus RNA alters virus production.
J. Virol.
63:4787-4796[Abstract/Free Full Text].
|
| 55.
|
Prats, A.,
G. DeBilly,
P. Wang, and J.-L. Darlix.
1989.
A CUG initiation codon is used for the synthesis of a cell surface antigen coded by MuLV.
J. Mol. Biol.
205:363-372[CrossRef][Medline].
|
| 56.
|
Pyronnet, S.,
L. Pradayrol, and N. Sonenberg.
2000.
A cell cycle-dependent internal ribosome entry site.
Mol. Cell
5:607-616[CrossRef][Medline].
|
| 57.
|
Ramesh, N., and W. R. Osborne.
1991.
Assay of neomycin phosphotransferase activity in cell extracts.
Anal. Biochem.
193:316-318[CrossRef][Medline].
|
| 58.
|
Sonenberg, N.
1993.
Remarks on the mechanism of ribosome binding to eukaryotic mRNAs.
Gene Expr.
3:317-323[Medline].
|
| 59.
|
Sonstegard, T. S., and P. B. Hackett.
1996.
Autogenous regulation of RNA translation and packaging by Rous sarcoma virus Pr76gag.
J. Virol.
70:6642-6652[Abstract/Free Full Text].
|
| 60.
|
Vagner, S.,
A. Waysbort,
M. Marenda,
M. C. Gensac,
F. Amalric, and A. C. Prats.
1995.
Alternative translation initiation of the Moloney murine leukemia virus mRNA controlled by internal ribosome entry involving the p57/PTB splicing factor.
J. Biol. Chem.
270:20376-20383[Abstract/Free Full Text].
|
| 61.
|
Wang, Z.,
P. Fang, and M. S. Sachs.
1998.
The evolutionarily conserved eukaryotic arginine attenuator peptide regulates the movement of ribosomes that have translated it.
Mol. Cell. Biol.
18:7528-36[Abstract/Free Full Text].
|
| 62.
|
Wang, Z.,
A. Gaba, and M. S. Sachs.
1999.
A highly conserved mechanism of regulated ribosome stalling mediated by fungal arginine attenuator peptides that appears independent of the charging status of arginyl-tRNAs.
J. Biol. Chem.
274:37565-37574[Abstract/Free Full Text].
|
| 63.
|
Wang, Z., and M. S. Sachs.
1997.
Arginine-specific regulation mediated by the Neurospora crassa arg-2 upstream open reading frame in a homologous, cell-free in vitro translation system.
J. Biol. Chem.
272:255-261[Abstract/Free Full Text].
|
| 64.
|
Wang, Z., and M. S. Sachs.
1997.
Ribosome stalling is responsible for arginine-specific translational attenuation in Neurospora crassa.
Mol. Cell. Biol.
17:4904-4913[Abstract].
|
| 65.
|
Weiss, R. T. N.,
H. Varmus, and J. Coffin.
1985.
RNA tumor viruses, 2nd ed.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
Journal of Virology, December 2000, p. 11581-11588, Vol. 74, No. 24
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Bolinger, C., Yilmaz, A., Hartman, T. R., Kovacic, M. B., Fernandez, S., Ye, J., Forget, M., Green, P. L., Boris-Lawrie, K.
(2007). RNA helicase A interacts with divergent lymphotropic retroviruses and promotes translation of human T-cell leukemia virus type 1. Nucleic Acids Res
0: gkm124v1-14
[Abstract]
[Full Text]
-
Baird, S. D., Turcotte, M., Korneluk, R. G., Holcik, M.
(2006). Searching for IRES. RNA
12: 1755-1785
[Abstract]
[Full Text]
-
Kanevsky, I., Vasilenko, N., Dumay-Odelot, H., Fosse, P.
(2003). In vitro characterization of a base pairing interaction between the primer binding site and the minimal packaging signal of avian leukosis virus genomic RNA. Nucleic Acids Res
31: 7070-7082
[Abstract]
[Full Text]
-
Alvarez, E., Menendez-Arias, L., Carrasco, L.
(2003). The Eukaryotic Translation Initiation Factor 4GI Is Cleaved by Different Retroviral Proteases. J. Virol.
77: 12392-12400
[Abstract]
[Full Text]
-
Brasey, A., Lopez-Lastra, M., Ohlmann, T., Beerens, N., Berkhout, B., Darlix, J.-L., Sonenberg, N.
(2003). The Leader of Human Immunodeficiency Virus Type 1 Genomic RNA Harbors an Internal Ribosome Entry Segment That Is Active during the G2/M Phase of the Cell Cycle. J. Virol.
77: 3939-3949
[Abstract]
[Full Text]
-
Butsch, M., Boris-Lawrie, K.
(2002). Destiny of Unspliced Retroviral RNA: Ribosome and/or Virion?. J. Virol.
76: 3089-3094
[Full Text]
-
Hellen, C. U.T., Sarnow, P.
(2001). Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev.
15: 1593-1612
[Full Text]